Development and validation of baseline predictive biomarkers for response to immuno-checkpoint treatments in the context of multiline and multitherapy cohorts using EpiSwitch™ epigenetic profiling

Development and validation of baseline predictive biomarkers for response to immuno-checkpoint treatments in the context of multiline and multitherapy cohorts using EpiSwitch™ epigenetic profiling

by oxfordbiodynamics

Development and validation of baseline predictive biomarkers for response to avelumab in second-line (2L) non-small cell lung cancer(NSCLC) using EpiSwitch™ epigenetic profiling

Development and validation of baseline predictive biomarkers for response to avelumab in second-line (2L) non-small cell lung cancer(NSCLC) using EpiSwitch™ epigenetic profiling

by oxfordbiodynamics

Ectopic gene deregulations and chromosome conformations: integrating novel molecular testing into clinical applications, from leukemias to gliomas

Handbook of Biomarkers and Precision Medicine, 1st Edition

by Aroul Ramadass

Epigenetic chromatin conformation changes in peripheral blood can detect thyroid cancer.

Surgery (2018) Oct 27. pii: S0039-6060(18)30622-6

by Aroul Ramadass

Genomic architecture differences at the HTT locus underlie symptomatic and pre-symptomatic cases of Huntington’s disease.

F1000Research (2018), 7:1757

by Aroul Ramadass

Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis.

EBioMedicine (2018) Volume 33, Pages 169–184

by Aroul Ramadass

The Chromosomal Conformation Signature: A New Kid on the Block in ALS Biomarker Research?

EBioMedicine (2018) Volume 33, Pages 6–7

by Aroul Ramadass

Chromosome conformation signatures as a clinical tool for diagnosis, prognosis and disease understanding in ALS

ENCALS (2018) 20-22 June, Oxford, UK.

by Aroul Ramadass

White blood cells from Prostate cancer patients carry distinct Chromosome Conformations.

J of Urology; 199(4S): e452, 2018

by Aroul Ramadass

Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis.

J Transl Med (2018) 16:18

by Aroul Ramadass